Understanding Cisplatin Resistance in HeLa Cells
Author Information
Author(s): Juan D. Chavez, Michael R. Hoopmann, Chad R. Weisbrod, Kohji Takara, James E. Bruce
Primary Institution: Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America
Hypothesis
How do protein expression changes contribute to cisplatin resistance in HeLa cells?
Conclusion
The study identified 374 proteins with significantly altered expression levels associated with cisplatin resistance in HeLa cells.
Supporting Evidence
- 856 proteins were identified and quantified in the study.
- 374 proteins showed significantly altered expression levels between resistant and sensitive HeLa cells.
- Several proteins identified have been previously linked to drug resistance.
Takeaway
Researchers looked at how proteins change in cancer cells that resist a common drug called cisplatin, finding many proteins that could help explain why the drug doesn't work.
Methodology
The study used stable isotope labeling with amino acids in cell culture (SILAC) and mass spectrometry to analyze protein expression levels.
Potential Biases
The shotgun proteomics approach may introduce bias towards more abundant proteins.
Limitations
The study primarily focused on proteins that were abundant, potentially missing less abundant proteins.
Participant Demographics
HeLa cells, a cervical cancer cell line.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website